Poster (Scientific congresses and symposiums)
Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy
Verstockt, Bram; Vieujean, Sophie; Truyens, Marie et al.
202318th Congress of European Crohn's and Colitis Organisation 2023
Peer reviewed
 

Files


Full Text
ECCO_confer_HS_abstract.docx
Author preprint (40.61 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Gastroenterology & hepatology
Author, co-author :
Verstockt, Bram;  University Hospitals Leuven, KU Leuven, Leuven, Belgium
Vieujean, Sophie  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Truyens, Marie;  University Hospital Ghent, Belgium
Julsgaard, Mette;  Aarhus University Hospital, Aarhus, Denmark
Pugliese, Daniela;  Fondazione Policlinico “A Gemelli” IRCSS, Roma, Italy
Aslan, Devrim;  University Hospitals Leuven, KU Leuven, Leuven, Belgium
Prokopic, Michal;  University Hospital, Martin, Slovakia
Lim, Samuel;  Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Viganò, Chiara;  San Gerardo Hospitol, University of Milan Bicocca Monza, Italy
Festa, Stefano;  San Filippo Neri Hospital, Rome, Italy
Ramos, Laura;  Hospital Universitario de Canarias, Spain
Plaza, Rocio;  Hospital Intana Leonor, Madrid, Spain
Noviello, Daniele
Savarino, Edoardo;  University of Paduo, Azienda Ospedaliera di Padova, Italy
Drobne, David;  University Medical Centre Ljubiljana, Slovenia
Imperatore, Nicola;  Cardarelli Hospital of Naples, Italy
Ribaldone, Davide G.;  Università degli Studi di Torino, Italy
Van Dongen, Jurgen;  AZ Sint Maarten, Mechelen, Belgium
Teich, Niels;  Internistische Gemeinschaftspraxis für Verdauungs, Germany
Wahed, Mahmood;  Chelsea and Westminster NHS Foundation Trust, London, UK
Barbeiro, Brigida;  University of Paduo, Azienda Ospedaliera di Padova, Italy
Goren, Idan;  Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA
More authors (12 more) Less
Language :
English
Title :
Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy
Publication date :
March 2023
Event name :
18th Congress of European Crohn's and Colitis Organisation 2023
Event place :
Copenhague, Denmark
Event date :
1-4 March, 2023
By request :
Yes
Audience :
International
Peer reviewed :
Peer reviewed
Available on ORBi :
since 16 January 2023

Statistics


Number of views
32 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi